Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

21

Number of overlapping holdings

16.5%

% of XBI's 128 holdings also in IDNA

50.0%

% of IDNA's 46 holdings also in XBI

Overlap by Weight
Sector Drift (XBI minus IDNA)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in XBI
Weight
in IDNA
Overlap
CRISPR THERAPEUTICS AG 1.9% 4.6% 1.9%
BLUEPRINT MEDICINES CORP. 1.7% 5.6% 1.7%
BEAM THERAPEUTICS, INC. 1.5% 4.2% 1.5%
EXELIXIS INC 1.3% 5.4% 1.3%
REGENERON PHARMACEUTICALS 1.3% 5.2% 1.3%

Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to IDNA
MIRATI THERAPEUTICS INC 2.1%
TG THERAPEUTICS INC 1.6%
IONIS PHARMACEUTICALS, INC. 1.6%
APELLIS PHARMACEUTICALS, INC. 1.5%
IMMUNOVANT INC 1.4%
SEATTLE GENETICS INC 1.4%
HALOZYME THERAPEUTICS INC 1.4%
BRIDGEBIO PHARMA, INC. 1.4%
VERTEX PHARMACEUTICALS INC 1.4%
IMMUNOGEN INC 1.4%
XBI Underweight Relative to IDNA
BIONTECH SE SPONSORED ADR -4.4%
SANOFI-AVENTIS -4.4%
TAKEDA PHARMACEUTICAL CO LTD -4.2%
EXELIXIS INC -4.1%
GINKGO BIOWORKS HOLDINGS INC CLASS A -4.1%
ROCHE HOLDING LTD -4.0%
REGENERON PHARMACEUTICALS -3.9%
BEIGENE, LTD. -3.9%
GENMAB A/S -3.9%
BLUEPRINT MEDICINES CORP. -3.9%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY